(NASDAQ: ANGO) Angiodynamics's forecast annual revenue growth rate of 5.9% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.85%.
Angiodynamics's revenue in 2025 is $283,320,000.On average, 3 Wall Street analysts forecast ANGO's revenue for 2026 to be $12,386,755,009, with the lowest ANGO revenue forecast at $12,283,613,265, and the highest ANGO revenue forecast at $12,543,497,975.
In 2027, ANGO is forecast to generate $12,901,651,592 in revenue, with the lowest revenue forecast at $12,901,651,592 and the highest revenue forecast at $12,901,651,592.